BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coppo P, Adrie C, Azoulay E, Leleu G, Oksenhendler E, Galicier L, Le Gall JR, Bussel A, Schlemmer B. Infectious diseases as a trigger in thrombotic microangiopathies in intensive care unit (ICU) patients? Intensive Care Med 2003;29:564-9. [DOI: 10.1007/s00134-003-1676-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Galic S, Csuka D, Prohászka Z, Turudic D, Dzepina P, Milosevic D. A case report of a child with sepsis induced multiorgan failure and massive complement consumption treated with a short course of Eculizumab: A case of crosstalk between coagulation and complement? Medicine (Baltimore) 2019;98:e14105. [PMID: 30681570 DOI: 10.1097/MD.0000000000014105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Vural F, Donmez A, Çagˇirgan S, Tombulogˇlu M. Local experience with thrombotic thrombocytopenic purpura from the western part of Turkey. Transfusion and Apheresis Science 2006;34:163-9. [DOI: 10.1016/j.transci.2005.09.039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
3 Bahloul M, Ben Hamida C, Dammak H, Chaari L, Kallel H, Chelly H, Rekik N, Bouaziz M. Les microangiopathies thrombotiques en réanimation. Annales Françaises d'Anesthésie et de Réanimation 2006;25:820-7. [DOI: 10.1016/j.annfar.2006.04.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Abraham E, Andrews P, Antonelli M, Brochard L, Brun-Buisson C, Dobb G, Fagon JY, Groeneveld J, Mancebo J, Metnitz P, Nava S, Pinsky M, Radermacher P, Ranieri M, Richard C, Tasker R, Vallet B. Year in review in Intensive Care Medicine-2003. Part 1: Respiratory failure, infection and sepsis. Intensive Care Med 2004;30:1017-31. [PMID: 15170528 DOI: 10.1007/s00134-004-2321-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
5 Asherson RA, Cervera R, Merrill JT. Thrombotic microangiopathic antiphospholipid syndromes: a continuum of conditions? Future Rheumatology 2006;1:355-64. [DOI: 10.2217/17460816.1.3.355] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
6 Morgand M, Buffet M, Busson M, Loiseau P, Malot S, Amokrane K, Fortier C, London J, Bonmarchand G, Wynckel A, Provôt F, Poullin P, Vanhille P, Presne C, Bordessoule D, Girault S, Delmas Y, Hamidou M, Mousson C, Vigneau C, Lautrette A, Pourrat J, Galicier L, Azoulay E, Pène F, Mira JP, Rondeau E, Ojeda-Uribe M, Charron D, Maury E, Guidet B, Veyradier A, Tamouza R, Coppo P; Thrombotic Microangiopathies Reference Center. High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center. Transfusion 2014;54:389-97. [PMID: 23711330 DOI: 10.1111/trf.12263] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
7 Cserti CM, Landaw S, Uhl L. Do infections provoke exacerbations and relapses of thrombotic thrombocytopenic purpura? J Clin Apher 2007;22:21-5. [PMID: 17285617 DOI: 10.1002/jca.20114] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
8 Raval JS, Harm SK, Rollins-raval MA, Kiss JE. Seasonal distribution of severe ADAMTS13 deficient idiopathic thrombotic thrombocytopenic purpura: Seasonal Distribution of Idiopathic TTP. J Clin Apheresis 2014;29:113-9. [DOI: 10.1002/jca.21300] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
9 Park YA, Schultz EF, Hay SN, Brecher ME. Thrombotic thrombocytopenic purpura and urinary tract infections: is there a connection? Am J Clin Pathol 2011;135:85-8. [PMID: 21173128 DOI: 10.1309/AJCPGM0SC6KOTCAN] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
10 Herget-Rosenthal S. Thrombotic microangiopathies--an issue for intensivists? Acta Clin Belg 2007;62 Suppl 2:385-8. [PMID: 18284005 DOI: 10.1179/acb.2007.086] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
11 Kravitz MS, Shoenfeld Y. Thrombocytopenic conditions-autoimmunity and hypercoagulability: commonalities and differences in ITP, TTP, HIT, and APS. Am J Hematol 2005;80:232-42. [PMID: 16247748 DOI: 10.1002/ajh.20408] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
12 Hussein EA. Idiopathic TTP in the Middle East: Epidemiology and clinical outcomes in infection associated episodes. Transfus Apher Sci 2020;59:102916. [PMID: 32878734 DOI: 10.1016/j.transci.2020.102916] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Chan PK, To KF, Wu A, Tse GM, Chan KF, Lui SF, Sung JJ, Tam JS, Tomlinson B. Human metapneumovirus-associated atypical pneumonia and SARS. Emerg Infect Dis 2004;10:497-500. [PMID: 15109421 DOI: 10.3201/eid1003.030513] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
14 Tiscia GL, Favuzzi G, De Laurenzo A, Cappucci F, Fischetti L, di Mauro L, Miscio G, Mirijello A, Chinni E, Grandone E; CSS COVID-19 Group . Reduction of ADAMTS13 Levels Predicts Mortality in SARS-CoV-2 Patients. TH Open 2020;4:e203-6. [PMID: 32879905 DOI: 10.1055/s-0040-1716379] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
15 Thoreau B, von Tokarski F, Bauvois A, Bayer G, Barbet C, Cloarec S, Mérieau E, Lachot S, Garot D, Bernard L, Gyan E, Perrotin F, Pouplard C, Maillot F, Gatault P, Sautenet B, Rusch E, Frémeaux-Bacchi V, Vigneau C, Fakhouri F, Halimi JM. Infection in Patients with Suspected Thrombotic Microangiopathy Based on Clinical Presentation. Clin J Am Soc Nephrol 2021;16:1355-64. [PMID: 34497111 DOI: 10.2215/CJN.17511120] [Reference Citation Analysis]
16 Park YA, Poisson JL, Mcbee MT, Afenyi-annan A. Seasonal association of thrombotic thrombocytopenic purpura: SEASONAL OCCURRENCE OF TTP. Transfusion 2012;52:1530-4. [DOI: 10.1111/j.1537-2995.2011.03481.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
17 Peigne V, Azoulay E, Coquet I, Mariotte E, Darmon M, Legendre P, Adoui N, Marfaing-Koka A, Wolf M, Schlemmer B, Veyradier A. The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation. Crit Care 2013;17:R273. [PMID: 24238574 DOI: 10.1186/cc13115] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
18 Evans MW, Vaughan LB, Giffi VS, Zimrin AB, Hess JR. Rituximab Treatment for Thrombotic Thrombocytopenic Purpura Associated with Human Immunodeficiency Virus Failing Extensive Treatment with Plasma Exchange: A Report of Two Cases. AIDS Patient Care and STDs 2010;24:349-52. [DOI: 10.1089/apc.2009.0313] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
19 Cataland SR, Jin M, Smith E, Stanek M, Wu HM. Full evaluation of an acquired case of thrombotic thrombocytopenic purpura following the surgical resection of glioblastoma multiforme. Journal of Thrombosis and Haemostasis 2006;4:2733-7. [DOI: 10.1111/j.1538-7836.2006.02217.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
20 López-López L, Rivera-Rodríguez N, Vilá LM. Nitrofurantoin-induced microangiopathic haemolytic anaemia and thrombocytopaenia in a patient with systemic lupus erythematosus. BMJ Case Rep 2012;2012:bcr-2012-006507. [PMID: 22977056 DOI: 10.1136/bcr-2012-006507] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
21 Knöbl P. Treatment of thrombotic microangiopathy with a focus on new treatment options. Hamostaseologie 2018;33:149-59. [DOI: 10.5482/hamo-13-01-0004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
22 Sakamaki Y, Konishi K, Hayashi K, Hashiguchi A, Hayashi M, Kubota E, Saruta T, Itoh H. Renal thrombotic microangiopathy in a patient with septic disseminated intravascular coagulation. BMC Nephrol 2013;14:260. [PMID: 24279773 DOI: 10.1186/1471-2369-14-260] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
23 Douglas KW, Pollock KG, Young D, Catlow J, Green R. Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors: a single-institution experience. J Clin Apher 2010;25:47-53. [PMID: 20101677 DOI: 10.1002/jca.20226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.2] [Reference Citation Analysis]
24 Darmon M, Azoulay E, Thiery G, Ciroldi M, Galicier L, Parquet N, Veyradier A, Le Gall JR, Oksenhendler E, Schlemmer B. Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange. Crit Care Med 2006;34:2127-33. [PMID: 16763519 DOI: 10.1097/01.CCM.0000227659.14644.3E] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
25 Rachakonda AK, Kimmel PL. CKD in HIV-infected patients other than HIV-associated nephropathy. Adv Chronic Kidney Dis 2010;17:83-93. [PMID: 20005492 DOI: 10.1053/j.ackd.2009.09.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
26 Tomov S, Lazarchick J, Self S, Bruner E, Budisavljevic M. Kidney-limited thrombotic microangiopathy in patients with SLE treated with romiplostim. Lupus 2013;22:504-9. [DOI: 10.1177/0961203313477900] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]